Shuji Kanmura Selected Research

Rifamycins

4/2021

Efficacy of rifaximin, a poorly absorbed rifamycin antimicrobial agent, for hepatic encephalopathy in Japanese patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shuji Kanmura Research Topics

Disease

12	Neoplasms (Cancer) 01/2022 - 12/2014
7	Ulcerative Colitis 11/2022 - 06/2009
7	Hepatocellular Carcinoma (Hepatoma) 02/2022 - 04/2010
7	Fibrosis (Cirrhosis) 09/2021 - 11/2013
6	Colitis 01/2020 - 06/2009
6	Infections 01/2020 - 01/2008
5	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2022 - 02/2012
5	Inflammation (Inflammations) 09/2021 - 01/2015
4	Liver Diseases (Liver Disease) 02/2022 - 04/2010
3	Fatty Liver 05/2021 - 11/2013
3	Colonic Neoplasms (Colon Cancer) 08/2015 - 06/2009
2	Crohn Disease (Crohn's Disease) 11/2022 - 02/2021
2	Carcinogenesis 02/2022 - 01/2021
2	Non-alcoholic Fatty Liver Disease 02/2022 - 04/2015
2	Ascites 01/2021 - 07/2019
2	Ulcer 01/2021 - 01/2019
2	Necrosis 03/2019 - 12/2016
2	Insulin Resistance 12/2016 - 01/2008
2	Melanoma (Melanoma, Malignant) 11/2015 - 01/2015
2	Body Weight (Weight, Body) 01/2015 - 04/2012
2	Viremia 08/2009 - 01/2008
2	Hepatitis C 08/2009 - 01/2008
1	Diplopia (Double Vision) 08/2022
1	Dysarthria (Spastic Dysarthria) 08/2022
1	Myasthenia Gravis 08/2022
1	Thymoma (Thymic Carcinoma) 08/2022
1	Autoimmune Hepatitis 08/2022
1	Liver Neoplasms (Liver Cancer) 02/2022
1	Diabetes Mellitus 02/2022
1	Liver Cirrhosis (Hepatic Cirrhosis) 02/2022
1	Hemorrhage 01/2022
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 11/2021
1	Chronic Kidney Failure (Chronic Renal Failure) 09/2021
1	Brain Diseases (Brain Disorder) 04/2021
1	Hepatic Encephalopathy 04/2021
1	Acute Kidney Injury (Acute Renal Failure) 01/2021
1	Esophageal Squamous Cell Carcinoma 01/2021
1	Squamous Cell Carcinoma of Head and Neck 01/2021
1	Neuroendocrine Carcinoma 01/2020

Drug/Important Bio-Agent (IBA)

9	Biomarkers (Surrogate Marker)IBA 02/2022 - 06/2009
5	Dextran SulfateIBA 01/2020 - 04/2012
5	CytokinesIBA 03/2019 - 04/2012
5	human neutrophil peptide 1IBA 01/2017 - 04/2012
4	EnzymesIBA 07/2018 - 06/2009
4	Peptides (Polypeptides)IBA 12/2016 - 06/2009
3	Therapeutic UsesIBA 04/2021 - 01/2015
3	ImmunosorbentsIBA 03/2017 - 06/2009
3	Complement System Proteins (Complement)IBA 08/2013 - 04/2010
2	AdrenomedullinIBA 11/2022 - 01/2021
2	SteroidsIBA 08/2022 - 01/2021
2	Serine C-PalmitoyltransferaseIBA 02/2022 - 04/2015
2	Messenger RNA (mRNA)IBA 02/2022 - 12/2016
2	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2020
2	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 09/2021 - 01/2019
2	Fetal Proteins (Fetoprotein)IBA 09/2021 - 04/2015
2	Tolvaptan FDA Link 01/2021 - 07/2019
2	Ethanol (Ethyl Alcohol)IBA 01/2021 - 01/2017
2	DiureticsIBA 01/2021 - 07/2019
2	InterleukinsIBA 03/2019 - 11/2015
2	CDAA (Randox)IBA 12/2016 - 11/2013
2	Choline (Choline Chloride)IBA 12/2016 - 11/2013
2	Amino Acids FDA Link 12/2016 - 11/2013
2	Interleukin-6 (Interleukin 6)IBA 12/2016 - 12/2016
2	Glycoproteins (Glycoprotein)IBA 11/2015 - 01/2015
2	AntigensIBA 08/2009 - 01/2008
1	Biological ProductsIBA 11/2022
1	Immunoglobulin G (IgG)IBA 08/2022
1	Prednisolone (Predate)FDA LinkGeneric 08/2022
1	Tacrolimus (Prograf)FDA LinkGeneric 08/2022
1	SphingolipidsIBA 02/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 02/2022
1	Hyaluronic Acid (Hyaluronan)IBA 02/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Capsules (Microcapsules)IBA 01/2022
1	CreatinineIBA 01/2022
1	Serum AlbuminIBA 01/2022
1	AlbuminsIBA 11/2021
1	lentil lectinIBA 09/2021
1	Pyruvaldehyde (Methylglyoxal)IBA 09/2021
1	Urea (Carbamide)FDA LinkGeneric 05/2021
1	NitrogenIBA 05/2021
1	RifamycinsIBA 04/2021
1	Rifaximin (L 105)FDA Link 04/2021
1	Anti-Infective Agents (Microbicides)IBA 04/2021
1	DisaccharidesIBA 04/2021
1	Infliximab (Remicade)FDA Link 02/2021
1	CollagenIBA 01/2021
1	GelatinIBA 01/2021
1	Natriuretic AgentsIBA 01/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	aldehyde dehydrogenase (NAD(P)+) (acetaldehyde dehydrogenase)IBA 01/2021
1	AcetaldehydeIBA 01/2021
1	daclatasvirIBA 01/2020
1	Chromogranin AIBA 01/2020
1	somatostatin receptor 2IBA 01/2020

Therapy/Procedure

9	Therapeutics 08/2022 - 08/2015
3	Drug Therapy (Chemotherapy) 08/2022 - 12/2014
1	Plasmapheresis 08/2022
1	Thymectomy 08/2022
1	Peritoneal Dialysis 09/2021